OR WAIT null SECS
© 2022 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2022 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
August 08, 2022
Inaugural recipients will use funds to support infrastructure, student mental health, and programs for children with behavioral challenges.
July 12, 2022
What are the biggest challenges facing both clinicians and patients, and how can we address them?
July 08, 2022
A psychiatrist lists the top 8 most pressing issues in MDD, from training to accessibility.
June 30, 2022
Does a computational approach to the mind pave the way for practicing a biopsychosocial psychiatry?
June 14, 2022
How can a greater emphasis on valued experiences both promote well-being and alleviate stress in patients?
June 06, 2022
The American Foundation for Suicide Prevention collaborates with Most Days, a mental health app, to provide suicide prevention expertise and content. Learn more about the partnership here.
May 19, 2022
Axsome Therapeutics announced the robust antidepressant efficacy demonstrated in this latest study.
May 09, 2022
Home environments have a clear impact on depression treatment outcomes.
May 06, 2022
In this CME, review novel, currently available, and promising pharmacological treatment options for treatment-resistant depression.
May 02, 2022
Zuranolone, a drug for the treatment of major depressive disorder and postpartum disorder, is on a rolling submission of a new drug application.